SAB Biotherapeutics Inc. (SABS)
1.19
-0.06 (-4.80%)
At close: Apr 03, 2025, 3:59 PM
1.22
2.17%
After-hours: Apr 03, 2025, 06:02 PM EDT
SAB Biotherapeutics Revenue
SAB Biotherapeutics reported an annual revenue of $1.32M, reflecting a -40.94% growth. For the quarter ending December 31, 2024, SAB Biotherapeutics generated $114.7K in revenue.
Revenue (ttm)
$1.32M
Revenue Growth
-40.94%
Price / Sales Ratio
26.54
Revenue / Employee
$23.2K
Employees
57
Market Cap
11.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.32M | -40.94% |
| Dec 31, 2023 | 2.24M | -90.63% |
| Dec 31, 2022 | 23.9M | -60.73% |
| Dec 31, 2021 | 60.88M | +10.21% |
| Dec 31, 2020 | 55.24M | n/a |